CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 4 Shares withheld for taxes Chief Scientific Officer gave up 7,102 shares (to pay taxes)
- 4 Shares withheld for taxes CAO/SVP, Finance gave up 1,913 shares (to pay taxes)
- 4 Open-market sale Chief Executive Officer sold 100,000 shares at $1.08 ($108,000)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 100,000 shares at $1.28 ($128,000)
- 8-K Event Other events
- 8-K Event Other events
- 4 Grant or award Chief Scientific Officer acquired 315,924 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CAO/SVP, Finance acquired 122,951 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 1,475,410 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 95,809 shares at $1.43 ($137,007)
- 8-K Event Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
Page 13 of 45 · 895 filings